IL2 and neoplasm: Furthermore, as shown in Figure 5, s.c. therapeutic administration of L. casei BL23 increased CD3 (Figure 5A) and IL-2 levels (Figure 5B) and reduced Nkp46 levels (Figure 5C) in tumor sections.